Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Crocs, Inc. (CROX) vs Figs Inc (FIGS) Price & Performance

Crocs, Inc.Trade

Price performance (Past 24H)

Key statistics

Crocs, Inc. vs Figs Inc — how do they compare? Crocs, Inc. trades at $131.73 (market cap $6.63B), while Figs Inc trades at $14.15 (market cap $2.39B). The key difference: Crocs, Inc. is far larger — about 2.8× Figs Inc's market cap, and Crocs, Inc. is trading nearer its 52-week high, Figs Inc nearer its low. Which is the better fit depends on your goals.

CROXFIGS
Market Cap
$6.63B$2.39B
Sector
Consumer StaplesConsumer Cyclical
52-Week High
$141.19$17.12
52-Week Low
$73.39$6.27
Enterprise Value
$8.14B$2.15B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Crocs, Inc.

Crocs (CROX) trades at $136.62, up 1.82% with strong technical momentum and bullish moving averages. The company has delivered three consecutive earnings beats, with Q2 2026 EPS of $4.55 exceeding expectations. Despite a net loss in 2025 due to tax impacts, profitability metrics remain robust with 57.47% gross margins and 42.3% ROE. Recent news highlights tax strategy scrutiny but also strong DTC growth and raised 2026 guidance.

The stock presents value with a 12.12 P/E ratio below industry averages, supported by analyst consensus of $140.43 price target. Key risks include HEYDUDE brand weakness, tariff pressures, and ongoing tax scrutiny. Upside potential exists from international expansion and direct-to-consumer growth, though near-term volatility may persist around earnings.

Figs Inc

FIGS stock surged 26.87% to $14.26, supported by strong Q2 2026 earnings that beat estimates with $0.11 EPS and 29% revenue growth. The technical outlook is bullish with moving averages aligned positively, while fundamentals show improving profitability with a net income margin of 8.72% and robust gross margins near 69%. Recent news highlights institutional buying and raised full-year guidance, reflecting strong operational momentum.

The outlook remains positive given consistent earnings beats and upward revenue revisions, though the stock's high P/E of 43.21 suggests premium valuation risks. Key investor risks include cost pressures from tariffs and freight, alongside competitive threats in the healthcare apparel space. Analyst consensus is bullish with a $19.50 price target, indicating potential upside from current levels.

Returns comparison

Trailing returns across standard periods

About Crocs, Inc.

Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company include Americas, Asia pacific, and EMEA.

Read more on CROX

About Figs Inc

FIGS Inc is a healthcare apparel company. It offers more fitted scrubs for men and women made of its proprietary fabric FIONx, which provides four-way stretch and has anti-odor, anti-wrinkle, and moisture-wicking properties.

Read more on FIGS